Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.

NCT06201611 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Neuropathy Peripheral

Interventions

DRUG: Nebivolol+ Standard care arm
DRUG: Epalrestat + Alpha Lipoic Acid +Standard care
DRUG: Standard care alone

Sponsor

St. John's Research Institute